Products for Research Use Only
RegisterLogin

Reozalimab

CAT: 0804-HY-P9996-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P9996-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Reozalimab is a bispecific antibody targeting to PD-1/PD-L1. Reozalimab mediates antibody-dependent cell cytotoxicity in cancer research[1][2].
CAS Number
2445259-99-2
Product Name Alternative
LY3434172
UNSPSC
12352203
Target
PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/reozalimab.html
Purity
99.90
Solubility
10 mM in DMSO|H2O
Smiles
[Reozalimab]
Molecular Weight
(143.55 kDa)
References & Citations
[1]Pattabiraman, et al. Synthetic IL-7 and IL-7-anti-PD-1 antibody immunocytokines for cancer therapy. World Intellectual Property Organization, WO2023281484 A1 2023-01-12.|[2]Reozalimab. IMGT/mAb-DB.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1

Alternative Products

CatalogName
BA6155-1Reozalimab
GTR18333924-01Reozalimab Antibody
HV974216-01Research Grade Reozalimab
E55B1292Reozalimab (Reference antibody)
GTR18697245-01Reozalimab Human Monoclonal Antibody
A135593Reozalimab Biosimilar (Monoclonal, Ig (G1-kappa_G1-lambda2) )
A4053Reozalimab (Ibi318) (Anti-PD-1 & PD-L1)
BIO1018SM-1mgAnti-human PD-1 & PD-L1 (Reozalimab Biosimilar)
PX-TA1879-01Reozalimab Biosimilar - Anti-PDCD1; CD274 mAb - Research Grade
GTR18699367-01Anti-PD-1 & PD-L1 Reference Antibody (Reozalimab Biosimilar)

Popular Products